Growth Metrics

Gyre Therapeutics (GYRE) Operating Margin (QoQ) (2010 - 2026)

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Quantum Biopharma 961,148.99 Bn 961,148.98 Bn -
2 Alterity Therapeutics 744,933.29 Bn 744,933.26 Bn -
3 Legend Biotech 2,540.00 Bn 2,539.71 Bn 242.10 Mn
4 Nanobiotix 2,199.85 Bn 2,199.78 Bn -
5 Akari Therapeutics 1,635.88 Bn 1,635.88 Bn -
6 Vertex Pharmaceuticals 111.32 Bn 104.07 Bn 2.59 Bn
7 Evaxion A 62.56 Bn 62.54 Bn -
8 Regeneron Pharmaceuticals 62.55 Bn 53.79 Bn 3.31 Bn
9 Alnylam Pharmaceuticals 39.57 Bn 36.56 Bn 959.66 Mn
10 Gyre Therapeutics 532.38 Mn 518.25 Mn 8.38 Mn

Historic Data

Download Data 🔒
DateValue
Mar 31, 2026 -1,913.00
Dec 31, 2025 -4,507.00
Sep 30, 2025 1,455.00
Jun 30, 2025 -220.00
Mar 31, 2025 792.00
Dec 31, 2024 -1,422.00
Sep 30, 2024 395.00
Jun 30, 2024 -1,704.00
Mar 31, 2024 36,723.00
Dec 31, 2023 -37,736.00
Sep 30, 2023 2,288.00
Jun 30, 2023 -977.00
Mar 31, 2023 4,886.00
Mar 31, 2022 -101,901.00
Dec 31, 2021 26,489.00
Sep 30, 2021 66,180.00
Jun 30, 2021 -22,967.00
Mar 31, 2021 -60,184.00
Dec 31, 2020 87,524.00
Sep 30, 2020 -75,581.00
Jun 30, 2020 -101,614.00
Mar 31, 2018 -10.95 Mn
Dec 31, 2017 1,541.00
Sep 30, 2017 350,653.00
Jun 30, 2017 -381,584.00
Mar 31, 2017 581,300.00
Dec 31, 2016 -211,175.00
Sep 30, 2016 -73,119.00
Jun 30, 2016 -31,468.00
Mar 31, 2016 10,183.00
Dec 31, 2015 -73,211.00
Sep 30, 2015 -330,799.00
Jun 30, 2015 19,496.00
Mar 31, 2015 -18,363.00
Dec 31, 2014 3,189.00
Sep 30, 2014 44,466.00
Jun 30, 2014 -11,684.00
Mar 31, 2014 1.37 Mn
Mar 31, 2013 252,194.00
Dec 31, 2012 -170,151.00
Sep 30, 2012 -109,673.00
Jun 30, 2012 3,362.00
Mar 31, 2012 6,224.00
Dec 31, 2011 -432.00
Sep 30, 2011 -3,683.00
Jun 30, 2011 -4,394.00
Mar 31, 2011 3,774.00
Dec 31, 2010 -178,340.00
Sep 30, 2010 -73,087.00